CB
Corami Biotech Inc.
SEC filingBiotechnology · Memphis, TN
Amount raised$230Ksold at filing
Total offering$1M$770K still open
Investors in the raise3count reported to the SEC
FiledApr 22, 2026first sale Feb 4, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Esra RoanExecutive Officer, Director
Brian WalshDirector
Nathaniel SmithDirector
Rifat PamukcuDirector
Executive officers, directors and promoters as listed on the Form D.